Table 1.
Clinicopathological features
| Cohort | ||||
|---|---|---|---|---|
| Parameter | All patients | Brazil | Costa Rica | Spain |
| Number of cases | 60 | 24 | 9 | 27 |
| Age at diagnosis, y (range) | 50 (29–75) | 53 (29–75) | 48 (36–70) | 48 (31–74) |
| Asian ancestry, n (%) | 3 (5) | 3 (13) | 0 (0) | 0 (0) |
| FIGO stage, n (%) | ||||
| Initial (I/II) | 39 (65) | 15 (63) | 6 (67) | 18 (67) |
| III | 17 (28) | 8 (33) | 2 (22) | 7 (26) |
| IV | 4 (7) | 1 (4) | 1 (11) | 2 (7) |
| Endometriosis, n (%) | 16 (27) | 7 (29) | 1 (11) | 8 (30) |
| TEEs, n (%) | 14 (23) | 8 (33) | 1 (11) | 5 (19) |
| Sensitivity to platinum, n (%) | ||||
| sensitive | 35 (66) | 12 (60) | 6 (75) | 17 (68) |
| resistant | 18 (34) | 8 (40) | 2 (25) | 8 (32) |
| unknown | 7 | 4 | 1 | 2 |
| Progression, n (%) | 36 (60) | 15 (63) | 3 (33) | 18 (67) |
| Outcome, n (%) | ||||
| Alive | 32 (53) | 11 (46) | 6 (67) | 15 (56) |
| Dead | 28 (47) | 13 (54) | 3 (33) | 12 (44) |
| Median follow-up, m | 36.3 | 39.7 | 15.6 | 36.3 |
| (range) | (0.43–210.6) | (0.43–123.7) | (3.1–41.0) | (1.1-210.6) |
FIGO International Federation of Gynecology and Obstetrics, TEE thromboembolic event